Pharis Mohideen - 29 Jan 2026 Form 4 Insider Report for DBV Technologies S.A. (DBVT)

Role: Chief Medical Officer
Signature: /s/ Virginie Boucinha, Attorney-in-Fact
Issuer symbol: DBVT
Transactions as of: 29 Jan 2026
Net transactions value: -$2,595
Form type: 4
Filing time: 02 Feb 2026, 16:30:20 UTC
Previous filing: 25 Nov 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Mohideen Pharis	Chief Medical Officer	C/O DBV TECHNOLOGIES S.A., 107, AVENUE DE LA REPUBLIQUE, CHATILLON, FRANCE	/s/ Virginie Boucinha, Attorney-in-Fact	02 Feb 2026	0001760395

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DBVT	Ordinary Shares	Sale	$2,595	-534	-0.37%	$4.86	144,995	29 Jan 2026	Direct	F1, F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The ordinary shares may be represented by American Depositary Shares, each of which currently represents five ordinary shares.
F2	Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units.
F3	This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.1974 to EURO 1.00 as of January 29, 2026.